Centogene Finalizes Receivables Transfer Deal
Company Announcements

Centogene Finalizes Receivables Transfer Deal

Centogene N.V. (CNTG) has released an update.

Centogene GmbH has entered into a KSA Receivables Transfer Agreement with Pharmaceutical Investment Company, where Centogene will transfer rights to receivables and associated rights under certain KSA Agreements. This move follows amendments to a previous loan agreement and is intended to be an absolute transfer, granting full benefits of ownership to the Pharmaceutical Investment Company without recourse to Centogene.

For further insights into CNTG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCentogene NV Announces Nasdaq Delisting
TheFlyCentogene receives delisting notice from Nasdaq
TheFlyCentogene publishes ROPAD study data on Parkinson’s disease in Brain
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App